Significance of the pharmacokinetics of antimicrobial drugs. 1978

P H Hinderling

Administration of an active drug to the intact human body leads to a "drug-body" interaction: the drug exerts its effect on the body, the body disposes of the drug. Administration of an antimicrobial drug to a human body infected with pathogenic bacteria leads to a "drug-bacteria" interaction in addition to "drug-body" and "bacteria-body" interactions. Of these complex interacting mechanisms only the disposition effect of the human body on antibacterial drugs and the effect of antimicrobial agents on bacteria have been quantified, analyzed, and are thus predictable. Postulates have been derived from the findings of these studies and have given the rationale for proper antimicrobial therapy under clinical conditions: antimicrobial actions are functions of the duration and concentration of the active antimicrobial principle at the physiological site of action. Optimal therapeutic efforts consider the need for individual treatment with respect to the choice and type of dosage regimen of the antimicrobial agent administered.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

P H Hinderling
May 1974, The Medical clinics of North America,
P H Hinderling
May 2009, Expert opinion on drug metabolism & toxicology,
P H Hinderling
January 1983, Pediatric pharmacology (New York, N.Y.),
P H Hinderling
November 1984, Journal of the American Veterinary Medical Association,
P H Hinderling
August 1998, Pharmacy world & science : PWS,
P H Hinderling
January 1990, Behavioural neurology,
P H Hinderling
October 2010, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!